Therefore, the novelty of our study is in the manipulation of cellular immunoregulatory actions by modifying the microenvironment of HUC-MSCs using IFN-γ, in addition to exploring whether functional exos released by HUC-MSCs are also altered and whether they exert a therapeutic effect on ALI. The gene discussed is IFNG; the disease is acute respiratory distress syndrome.